10th RSC-BMCS Fragment-based drug discovery meeting
Discover how fragment-based approaches are delivering drug candidates and shaping the future of drug discovery.
14–16 September, Churchill College, Cambridge (UK)
The aim of the 10th RSC-BMCS Fragment-based Drug Discovery meeting is to focus on case studies in fragment-based drug discovery that have delivered compounds to late-stage medicinal chemistry, preclinical or clinical programmes.
The Fragment series was started in 2007 and continues to feature over three-quarters of the presentations focused on case studies. This will be complemented by technology progress in high-concentration NMR, SPR, and X-ray screening.
Don’t miss Rupesh Chikhale, CCDC Research and Applications Scientist, presenting a paper on De Novo Design of ligands using Gen AI.
Find out more and register on the organisers’ website.